Back to Supplement Score
72
SCORE

Saffron (Crocus sativus)

Depression · Anxiety · Cognition
Tier 1 — Strong Evidence

What it is

Saffron stigma extract (Crocus sativus) demonstrates antidepressant activity comparable to fluoxetine in mild-moderate depression. The 2025 Cheng network meta-analysis (192 trials, 17,437 patients, PMID 40314175) identified saffron as one of only four nutraceutical monotherapies with efficacy SUPERIOR to standard antidepressants (SMD 0.69, 95% CI 0.34–1.04). Standard dose is 30 mg/day of standardised extract for 6–12 weeks. Tolerability is comparable to placebo. Caution with serotonergic drugs (SSRI, MAOI, tramadol) — additive serotonin syndrome risk.

Efficacy
4/5
Safety
4/5
Research
4/5
Onset
2/5
Cost
3/5
Drug-int.
3/5

Dose

28–30 mg/day standardised saffron extract (min 2% safranal + crocin)

Time of day & tips

Take with food or water at any time of day. Do not combine with SSRIs, SNRIs, or MAOIs — serotonin syndrome risk. Allow 4–8 weeks before assessing mood effects.

Cycling

Studies typically run 6-12 weeks. Safe for continuous use at 30 mg/day based on current evidence. No established cycling protocol.

Compare or learn more

Compare with another supplement →
Browse by symptom →
Open the full interactive view →

Educational reference, not medical advice. About · Methodology · Privacy · Terms